Medtronic’s planned $650 million acquisition of SPR Therapeutics has shone a global spotlight on temporary peripheral nerve stimulation, a minimally invasive, drug-free approach to chronic pain that could hold significant implications for community health services and home-based care across the UK. Continue reading Could A New Wave Of Nerve Stimulation Technology Transform Chronic Pain Care At Home?